Start Further Info FOR FURTHER INFORMATION CONTACT:Įlise Barringer, (410) 786–9222. You may send written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS–1793–P, Mail Stop C4–26–05, 7500 Security Boulevard, Baltimore, MD 21244–1850.įor information on viewing public comments, see the beginning of the Please allow sufficient time for mailed comments to be received before the close of the comment period. You may mail written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS–1793–P, P.O. You may submit electronic comments on this regulation toįollow the “Submit a comment” instructions. In commenting, please refer to file code CMS–1793–P.Ĭomments, including mass comment submissions, must be submitted in one of the following three ways (please choose only one of the ways listed): To be assured consideration, comments must be received at one of the addresses provided below, by September 11, 2023. 1896 (2022), relating to the adjustment of Medicare payment rates for drugs acquired under the 340B Program from calendar year (CY) 2018 through September 27th of CY 2022. This proposed rule describes the agency's proposed actions to comply with the remand from the district court to craft a remedy in light of the United States Supreme Court's decision inġ42 S. Start Preamble Start Printed 78 AGENCY:Ĭenters for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |